These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2516494)

  • 21. Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.
    Tóthová E; Fricová M; Kafková A; Stecová N; Guman T; Raffac S; Hlebasková M
    Neoplasma; 2000; 47(2):125-8. PubMed ID: 10985480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia.
    Wandl UB; Niederle N; Kranzhoff M; Seeber S
    Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.
    Claxton D; Deisseroth A; Talpaz M; Reading C; Kantarjian H; Trujillo J; Stass S; Gooch G; Spitzer G
    Blood; 1992 Feb; 79(4):997-1002. PubMed ID: 1371081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
    Anger B; Porzsolt F; Leichtle R; Heinze B; Bartram C; Heimpel H
    Blut; 1989 Jun; 58(6):275-8. PubMed ID: 2736308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies.
    Niederle N; Kloke O; Wandl UB; Becher R; Moritz T; Opalka B
    Leuk Lymphoma; 1993 Jan; 9(1-2):111-9. PubMed ID: 8477190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of alpha-interferons in chronic myelogenous leukaemia.
    Talpaz M
    Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
    [No Abstract]   [Full Text] [Related]  

  • 27. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
    Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
    Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
    Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
    [No Abstract]   [Full Text] [Related]  

  • 29. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
    Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
    N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
    Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
    Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic myelogenous leukemia with interferons alpha and gamma.
    Kloke O; May D; Wandl U; Becher R; Opalka B; Beer U; Niederle N
    Blut; 1990 Jul; 61(1):45-6. PubMed ID: 2117476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving approaches with interferon alfa in chronic myelogenous leukemia.
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotherapy of chronic myelogenous leukemia with interferon.
    Ozer H
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia].
    Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE
    Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy.
    Kantarjian HM; Giles FJ; O'Brien SM; Talpaz M
    Hematol Oncol Clin North Am; 1998 Feb; 12(1):31-80. PubMed ID: 9523225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation.
    Zhang H; Liang Z; Hu Y; Wang X; Wang B; Huang H
    Leuk Lymphoma; 2018 Dec; 59(12):3018-3019. PubMed ID: 29616854
    [No Abstract]   [Full Text] [Related]  

  • 37. Remission of Philadelphia positive chronic myelogenous leukemia associated with t(3;21) after bone marrow transplantation.
    Uriarte MR; Mori MA; de Bellis R; Cardoso H
    Cancer Genet Cytogenet; 1993 Jul; 68(2):122-5. PubMed ID: 8353803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; O'Brien S; Beran M; Koller C; Pierce S; Kornblau S; Estey E; Keating MJ; Talpaz M
    Leukemia; 1997 Oct; 11(10):1610-6. PubMed ID: 9324278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interferon therapy for chronic myelogenous leukemia].
    Shibata A; Hashimoto S
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.